Cargando…
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
SIMPLE SUMMARY: In the last decade, metabolic reprogramming has emerged as a driving characteristic of cancer cells. The MYC oncogene, a transcription factor, has become of growing interest as a fundamental driver of differential cancer cell metabolism. Furthermore, the non-essential amino acid glut...
Autores principales: | Tambay, Vincent, Raymond, Valérie-Ann, Bilodeau, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431116/ https://www.ncbi.nlm.nih.gov/pubmed/34503295 http://dx.doi.org/10.3390/cancers13174484 |
Ejemplares similares
-
Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature
por: Tambay, Vincent, et al.
Publicado: (2023) -
Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014) -
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation
por: Le Grand, Marion, et al.
Publicado: (2020) -
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
por: Zacharias, Niki Marie, et al.
Publicado: (2017) -
c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism
por: Gao, Ping, et al.
Publicado: (2009)